The National Health Service in England will offer CAR T-cell therapy to children with leukemia after striking a discount deal with Novartis.
Category: NASDAQ:NVS
The National Health Service in England will offer CAR T-cell therapy to children with leukemia after striking a discount deal with Novartis.